| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/18/2007 | US7309817 Plant alpha farnesene synthase and polynucleotides encoding same |
| 12/18/2007 | US7309816 Zinc finger proteins expressed in plant meristem |
| 12/18/2007 | US7309815 Nucleic acid compositions conferring disease resistance |
| 12/18/2007 | US7309814 Nucleic acid molecules encoding bacterial autoinducer inactivation protein as targets for engineering disease resistance |
| 12/18/2007 | US7309812 Mating a transgenic mouse whose genome encodes mouse perlecan, a large multidomain proteoglycan that binds and cross-links extracellular matrix (ECM) components and cell surface molecules, domains, with a second transgenic mouse whose genome encodes the human C terminal of A beta precursor protein |
| 12/18/2007 | US7309785 Attached to a heterologous, non-Cry35 protein (Bacillus sphaericus insecticidal toxin) or a second, different Cry35 protein; inhibiting a rootworm pest |
| 12/18/2007 | US7309781 growth hormone supergene family; prolongs circulating half-lives of protein therapeutics in the body so proteins do not have to be injected frequently; adding cysteine residues to non-essential regions using site-directed mutagenesis; covalently coupling a cysteine-reactive polymer via the added cysteine |
| 12/18/2007 | US7309780 Antibodies to natural killer cell activating factor II |
| 12/18/2007 | US7309778 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/18/2007 | US7309777 Antibodies against the PRO1556 polypeptide |
| 12/18/2007 | US7309776 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 12/18/2007 | US7309774 for drug screening enzyme inhibitors for making fibrin deposits or blood clots more susceptible to removal by plasmin; fluorescence resonance energy transfer (FRET); genetic engineering |
| 12/18/2007 | US7309773 High temperature extraction using alkaline solution of sodium bicarbonate to remove mucilage; concentration; isoelectric precipitation; crushing to recover oil and leave meal; egg white substitutes; feeds, foods, nutritional supplements, cosmetics |
| 12/18/2007 | US7309772 KCNQ5, a novel potassium channel |
| 12/18/2007 | US7309771 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors |
| 12/18/2007 | US7309770 PRO1757 polypeptides |
| 12/18/2007 | US7309769 PRO1487 polypeptides |
| 12/18/2007 | US7309768 PRO4347 polypeptides |
| 12/18/2007 | US7309767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
| 12/18/2007 | US7309765 PRO4349 polypeptides |
| 12/18/2007 | US7309764 PRO4401 polypeptide |
| 12/18/2007 | US7309763 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 12/18/2007 | US7309762 PRO1360 polypeptides |
| 12/18/2007 | US7309761 Membrane bound proteins; genetic engineering; libraries |
| 12/18/2007 | US7309760 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 12/18/2007 | US7309759 Indolicidin peptide analogues containing at least two basic amino acids; bactericide |
| 12/18/2007 | US7309694 Gene therapy; cytokine complex; anticancer agent |
| 12/18/2007 | US7309606 Administering apoE protein for reducing plasma cholesterol |
| 12/18/2007 | US7309604 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 12/18/2007 | US7309601 Ecteinascidia turbinata, biosynthesis of ecteinascidin compounds |
| 12/18/2007 | US7309598 gM-negative EHV-mutants |
| 12/18/2007 | US7309596 Amino acid sequence; protection of the plants against pathogens and predators; multi-proteinase inhibitor domains and will be useful in developing a range of transgenic plants with enhanced proteinase inhibitor expression |
| 12/18/2007 | US7309586 Chimeric coiled coil molecules |
| 12/18/2007 | US7309585 Protein, therapy, diagnosis of cancer, to elicit an immune response |
| 12/18/2007 | US7309584 Mutations of the MDR1 P-glycoprotein that improves its ability to confer resistance to chemotherapeutic drugs |
| 12/18/2007 | US7309583 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infection of mammals |
| 12/18/2007 | US7309577 G-protein protein coupled receptor fusion for use as tool in enhancing food taste; flavoring |
| 12/18/2007 | US7309576 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell |
| 12/18/2007 | US7309575 Purifying target proteins using post-synaptic density 95, discs-large and zonular occludens (PDZ1) domain and a no receptor potential A (NorpA) sequence soluble matrix |
| 12/18/2007 | US7309572 Growth hormone-regulatable liver genes and proteins, and uses thereof |
| 12/18/2007 | US7309495 For immunizing a cat against a hemorrhagic feline calicivirus (hFCV) |
| 12/18/2007 | US7309494 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; diagnostic kits for respiratory syncytial virus |
| 12/18/2007 | US7309492 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus |
| 12/18/2007 | US7309491 Heat shock protein-based vaccines and immunotherapies |
| 12/18/2007 | US7309489 Monoclonal antibody that binds to mouse CD40L; inhibit CD40-L or anti-CD40 mAb induced B cell stimulation, IL-4-induced IgE stimulation and IL-4 induced CD23 induction in B cells |
| 12/18/2007 | US7309488 capable of efficient and selective adsorption of an antibody against beta 1-adrenoceptor and/or an antibody against M2 muscarinic receptor occurring in a body fluid (e.g. blood, plasma or the like) without requiring a pretreatment |
| 12/18/2007 | US7309483 Reducing pathological neovascularization in a human by administering to the human an agent capable of interfering with Ang2-mediated biological effects |
| 12/18/2007 | US7309482 Durability, efficiency, bind with high affinity to hair, skin, and nails |
| 12/18/2007 | CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use |
| 12/18/2007 | CA2249390C Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor |
| 12/18/2007 | CA2235400C Cartilage/bone inducing materials for reparation |
| 12/18/2007 | CA2179562C Peptide useful in the separation and purification of immunoglobulins |
| 12/18/2007 | CA1341566C Immune response to tumors induced by anti-idiotype antibodies |
| 12/14/2007 | CA2549124A1 Method and a kit for the detection of adenoviruses |
| 12/13/2007 | WO2007143578A2 Perforin-2 proteins |
| 12/13/2007 | WO2007143451A2 Targeted delivery of oncolytic viruses, anti-tumor proteins, plasmids, toxins, hemolysins & chemotherapy |
| 12/13/2007 | WO2007143161A2 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods |
| 12/13/2007 | WO2007143104A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 12/13/2007 | WO2007142711A2 Methods for diagnosing and treating cancer |
| 12/13/2007 | WO2007142597A1 Method and use of lactic acid bacteria with increased acid tolerance |
| 12/13/2007 | WO2007142596A1 Use of selected lactic acid bacteria for reducing infantile colic |
| 12/13/2007 | WO2007142582A1 Fluorescent proteins and genes encoding them |
| 12/13/2007 | WO2007142381A1 Human short helical peptide-1 which has antimicrobial, antitumor, and immune stimulating activity and uses thereof |
| 12/13/2007 | WO2007142320A1 AMYLOID-β OLIGOMER, METHOD FOR PRODUCTION THEREOF, AND USE THEREOF |
| 12/13/2007 | WO2007142300A1 Method of producing lymphocytes |
| 12/13/2007 | WO2007142258A1 Anthocyanin synthesis regulatory gene, and use thereof |
| 12/13/2007 | WO2007142208A1 Temperature-responsive protein and polynucleotide, plasmid and cell expressing the temperature-responsive protein and method of using the temperature-responsive protein |
| 12/13/2007 | WO2007141971A1 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity |
| 12/13/2007 | WO2007141808A2 Extra-cellular matrix localized ferritin for iron uptake, storage, and stress tolerance |
| 12/13/2007 | WO2007141778A2 Development of follicle stimulating hormone agonists and antagonists in fish |
| 12/13/2007 | WO2007141309A2 Stabilized insulin-like growth factor polypeptides |
| 12/13/2007 | WO2007141131A1 Microfluidic device for controlled aggregation of spider silk |
| 12/13/2007 | WO2007141029A1 Specific protease inhibitors and their use in cancer therapy |
| 12/13/2007 | WO2007140983A1 FLUORESCENT PROTEINS wfCGFP, and use thereof |
| 12/13/2007 | WO2007140953A1 Peptide associated with rheumatic fever (parf) and its use as a diagnostic marker |
| 12/13/2007 | WO2007140667A1 A ptd-vp3 fusion protein as anti-tumor medecine and preparing process |
| 12/13/2007 | WO2007140619A1 Derivatized insulin oligomers |
| 12/13/2007 | WO2007140618A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease |
| 12/13/2007 | WO2007140545A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefore |
| 12/13/2007 | WO2007113837A8 N-terminal vdac variants and uses thereof |
| 12/13/2007 | WO2007110079A8 Targeted delivery of fgfr ligands into the brain |
| 12/13/2007 | WO2007107996A8 Novel nucleotide and amino acid sequences and methods of use thereof for diagnosis |
| 12/13/2007 | WO2007107563A3 Muteins of tear lipocalin with affinity for the t-cell coreceptor cd4 |
| 12/13/2007 | WO2007104736A3 Acylated single chain insulin |
| 12/13/2007 | WO2007102814A3 Recombinant mammalian molecules and method for production thereof |
| 12/13/2007 | WO2007101602A3 Chimeric kunitz domains and their use |
| 12/13/2007 | WO2007098415A3 Peptide based inhibition of capcna protein-protein interactions in cancer |
| 12/13/2007 | WO2007092370A3 Lingo-1 structure |
| 12/13/2007 | WO2007092059A3 Rna interference mediated inhibition of influenza virus gene expression using short interfering nucleic acid |
| 12/13/2007 | WO2007072461A3 Modified proteins comprising a bioactive peptide/protein linked to a sequence of aminoacids containing a human carbohydrate binding module (cbm), and development of a system for the administration of therapeutically active proteins and respective utilizations for biomedical purposes |
| 12/13/2007 | WO2007038171A3 Peptide nucleic acid based guanidinium compounds |
| 12/13/2007 | WO2007028983A8 Protein assay |
| 12/13/2007 | WO2007022123A3 Hybrid polypeptides with selectable properties |
| 12/13/2007 | WO2007009069A8 Heat lysis production of proteins |
| 12/13/2007 | WO2006123256A8 Hivcon: an hiv immunogen and uses thereof |
| 12/13/2007 | WO2006115548A3 Subunit vaccine against west nile viral infection |
| 12/13/2007 | WO2006076687A3 Elisa assays using prion-specific peptide reagents |
| 12/13/2007 | WO2006066153A3 Actinomadura chromoprotein, apoprotein, and gene cluster |
| 12/13/2007 | WO2005113019A3 Methods for the treatment of autoimmune diseases |
| 12/13/2007 | WO2005089182A3 Improved bacterial host cell for the direct expression of peptides |